Yazar "Tamussino, K" seçeneğine göre listele

Listeleniyor 1 - 3 / 3
  • Küçük Resim Yok
    Öğe
    Association between initial diagnostic procedure and hysteroscopy and abnormal peritoneal washing in patients with endometrial carcinoma
    (Wiley, 2002) Gücer, F; Sayin, C; Tamussino, K
    [Abstract Not Available]
  • Küçük Resim Yok
    Öğe
    Preoperative thrombocytosis is an independent prognostic factor in stage III and IV endometrial cancer
    (Int Inst Anticancer Research, 2000) Scholz, HS; Petru, E; Gücer, F; Haas, J; Tamussino, K; Winter, R
    Background: To identify prognostic factors in stage III and IV endometrial cancer with special attention to pretreatment platelet count. Materials and Methods: 59 patients with FIGO stage III or IV disease operated on between 1983 and 1993 were analyzed. Patients with preoperative thrombocytosis were compared with those without thrombocytosis. Prognostic factors were analyzed with a Cox proportional hazard model. Results: With the exception of age, there were no significant differences between patients with or without thrombocytosis. At multivariate analysis, five-year disease-free survival was influenced significantly by FIGO stage (stage III vs stage IV; p=0.009), thrombocytosis (p=0.02) and cervical involvement (p=0.024). Similarly, overall five-year survival was significantly influenced by stage (p<0.001), cervical involvement (p=0.005) and thrombocytosis (p=0.01). Age, histology, grade, myometrial invasion, lymph-vascular space involvement or spread to adnexae were not significantly associated with survival. Conclusion: Thrombocytosis is an independent prognostic factor in stage III and IV endometrial cancer.
  • Küçük Resim Yok
    Öğe
    Thrombocytosis in gynecologic malignancies
    (Int Inst Anticancer Research, 2004) Gücer, F; Tamussino, K; Keil, F; Balkanli-Kaplan, P; Yüce, MA
    Recent studies have addressed the prevalence and prognostic impact of thrombocytosis in various gynecologic and non-gynecologic malignancies. Thrombocytosis appears to be of prognostic value in certain patients with gynecologic malignancies. In this survey we review the published data and attempt to analyze the prognostic implications of thrombocytosis in patients with gynecologic malignancies.